was replaced by fluoride, and the two O-cyclopentyl groups were replaced by O-isopropyl groups. The DFP substrate was then rotated approximately 120° clockwise about the Ca 2+ -coordinating O-P bond axis ( Figure S1 ). This modification resulted in a reactive orientation positioned for in-line attack and also preserved the critical Ca 2+ coordination to the non-bridging oxygen of the substrate. Similarly, a model of (S)-sarin bound to DFPase was then constructed by replacing the appropriate O-isopropyl group with a methyl group.
A restrained classical MD simulation was performed on the DFPase:DFP and
DFPase:Sarin models to equilibrate the solvent around the enzyme and substrate. As described in the main text, harmonic restraints were applied to all non-hydrogen atoms. Further equilibration of the system was performed during a 35 ps trial PM6/MM umbrella sampling simulation according the same procedure followed for the production simulations (described in the main text). A configuration corresponding to the pentavalent phosphoenzyme intermediate was obtained from the end of the initial PM6/MM simulations. Starting from this structure, a series of constrained geometry optimizations were performed in which the reaction was driven in both the forward and reverse reaction directions along the A n D n reaction coordinate (see main text). For each constrained optimization along the path, 100 steps of conjugate gradient minimization were carried out. These optimized structures then served as starting points for PM6/MM umbrella sampling simulations (25 ps per window) that then served as starting points for the DFT/MM umbrella sampling simulations.
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